Ranitidine is an H2 blocker that is used in prescription strength for duodenal and gastric ulcers, gastroesophageal reflux, and as part of a multidrug regimen for the eradication of H. pylori to reduce the risk of duodenal ulcer recurrence.
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Acid reflux (GER gastroesophageal reflux) | 2 |
|
1 | ||||
| Irritable Bowel Syndrome (IBS) | 1 | 0 | |||||
| Stomach pain | 1 | 0 | |||||
| Stomach (gastric) ulcer pain | 1 | 0 | |||||
| gastrointestinal | 1 | 0 | |||||
| Other | 1 | 0 |
Mouse over the table for more information
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Side effects too severe
|
1 | 50% |
|
|
Other
|
1 | 50% |
|
See all 2 patients who’ve stopped taking Ranitidine Prescription
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 23, 2009.